Trial site
Azienda Ospedaliero-Universitaria Policlinico Umberto I
- 196running trials
- 65closed trials
The trials here
What the 262 trials at this site are about, from their registry records.
- Conditions
- High blood pressure23 trials
- Pulmonary arterial hypertension21 trials
- Multiple myeloma19 trials
- Acute myeloid leukaemia16 trials
- Alzheimer disease11 trials
- Myeloproliferative neoplasms10 trials
- Ulcerative colitis10 trials
- Acute lymphoblastic leukaemia9 trials
- Chronic myeloid leukaemia9 trials
- Childhood cancers8 trials
- Chronic lymphocytic leukaemia8 trials
- Head and neck cancer8 trials
- and 62 more
- Phase
- Phase 3164 trials
- Phase 268 trials
- Phase 412 trials
- Phase 2/311 trials
- Phase 1/26 trials
- Status
- Recruiting91 trials
- Active, not recruiting81 trials
- Completed65 trials
- Not yet recruiting23 trials
- Enrolling by invitation1 trial
- Suspended1 trial
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto13 trials
- AstraZeneca12 trials
- Hoffmann-La Roche11 trials
- Takeda10 trials
- Janssen Research & Development, LLC9 trials
- and 126 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
Recruiting
Recruiting
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
Recruiting
Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Recruiting
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
Recruiting
Recruiting
Showing 50 of 196.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia10 recruiting
- High blood pressure8 recruiting
- Pulmonary arterial hypertension7 recruiting
- Multiple myeloma6 recruiting
- Alzheimer disease5 recruiting
- Crohn's disease5 recruiting
- Myelodysplastic syndromes5 recruiting
- Myeloproliferative neoplasms5 recruiting
- Type 2 diabetes5 recruiting
- Amyloidosis4 recruiting
- Chronic lymphocytic leukaemia4 recruiting
- Chronic myeloid leukaemia4 recruiting
- Ulcerative colitis4 recruiting
- Childhood cancers3 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)3 recruiting
- COPD3 recruiting
- Graves' disease3 recruiting
- Haemophilia3 recruiting
- Head and neck cancer3 recruiting
- Immune thrombocytopenia (ITP)3 recruiting
- Lupus (SLE)3 recruiting
- Obesity3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Cushing's syndrome2 recruiting
- Heart failure2 recruiting
- Lewy body dementia2 recruiting
- Mantle cell lymphoma2 recruiting
- Metastatic breast cancer2 recruiting
- Multiple sclerosis2 recruiting
- Prostate cancer2 recruiting
- Thyroid cancer2 recruiting
- ALS (motor neurone disease)1 recruiting
- Asthma1 recruiting
- Atrial fibrillation1 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Cytomegalovirus infection1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Epilepsy1 recruiting
- Follicular lymphoma1 recruiting
- Hypothyroidism1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Meningioma1 recruiting
- Migraine1 recruiting
- Osteoarthritis1 recruiting
- Ovarian cancer1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Schizophrenia1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Recruiting
Completed
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis
Active, not recruiting
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
Completed
Completed
Efficacy and Safety of REL-1017 for Major Depressive Disorder
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
Completed
Recruiting
Completed
Completed
Completed
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Completed
Completed
Active, not recruiting
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Completed
Completed
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia.
Completed
GliflOzin in eLderly Diabetic patiENts: A praGmatic intraclass Evaluation trial
Completed
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
Completed
Completed
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
Completed
A Long-term Follow-up Study of Sotatercept for PAH Treatment
Active, not recruiting
Completed
Recruiting
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
Recruiting
Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Showing 50 of 65.
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026